Galmed Pharmaceuticals Ltd.
GLMD
$1.55
-$0.08-4.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -5.88M | -5.88M | -6.36M |
| Total Depreciation and Amortization | -- | -- | 97.00K | 97.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 708.00K | 708.00K | 603.00K |
| Change in Net Operating Assets | -- | -- | -844.00K | -844.00K | -550.00K |
| Cash from Operations | -- | -- | -5.92M | -5.92M | -6.27M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 568.00K | 568.00K | -119.00K |
| Cash from Investing | -- | -- | 568.00K | 568.00K | -119.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 6.19M | 6.19M | 6.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 6.19M | 6.19M | 6.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 831.00K | 831.00K | -206.00K |